Literature DB >> 24394496

A novel community-based buprenorphine program: client description and initial outcomes.

Amy M Daniels1, Elizabeth Salisbury-Afshar, Adam Hoffberg, Deborah Agus, Michael I Fingerhood.   

Abstract

The aims of this retrospective, descriptive study were to describe clients served by a buprenorphine program in a community-based recovery center and to present initial treatment outcomes. A record review was conducted for clients treated from July 2010 to August 2011. Client demographic, health, substance use, and treatment history data were abstracted from the records of the first 78 clients served. Buprenorphine and opiate use data were collected via urine toxicology reports, collected weekly among clients who remained enrolled in treatment. The average percentages of weeks spent opiate free and buprenorphine compliant were 83% (SD = 26%) and 95% (SD = 13%), respectively. When positive heroin toxicology and negative buprenorphine toxicology were replaced for the missing/unknown data, the average percentages of opiate-abstinent weeks and buprenorphine compliance were 60% (SD = 34%) and 74% (SD = 28%), respectively. Roughly half of all clients (49%) were successfully transitioned to continue treatment with buprenorphine in a primary care setting. Findings from this study demonstrate that buprenorphine treatment for opiate dependence can be incorporated into a community-based recovery center with high rates of opiate abstinence and treatment adherence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24394496     DOI: 10.1097/ADM.0000000000000004

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  7 in total

1.  Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.

Authors:  Noa Krawczyk; Megan Buresh; Michael S Gordon; Thomas R Blue; Michael I Fingerhood; Deborah Agus
Journal:  J Subst Abuse Treat       Date:  2019-05-09

2.  National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.

Authors:  Christopher M Jones; Melinda Campopiano; Grant Baldwin; Elinore McCance-Katz
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

3.  Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs.

Authors:  April Joy Damian; Tamar Mendelson; Deborah Agus
Journal:  Addict Behav       Date:  2017-05-10       Impact factor: 3.913

4.  Overcoming medication stigma in peer recovery: A new paradigm.

Authors:  Noa Krawczyk; Tianna Negron; Maia Nieto; Deborah Agus; Michael I Fingerhood
Journal:  Subst Abus       Date:  2018-04-04       Impact factor: 3.716

5.  Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City.

Authors:  C Truong; N Krawczyk; M Dejman; S Marshall-Shah; K Tormohlen; D Agus; J Bass
Journal:  Addict Behav       Date:  2019-01-17       Impact factor: 3.913

Review 6.  Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care.

Authors:  Jinhee Lee; Thomas F Kresina; Melinda Campopiano; Robert Lubran; H Westley Clark
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

7.  Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.

Authors:  Noa Krawczyk; Sean T Allen; Kristin E Schneider; Keisha Solomon; Hridika Shah; Miles Morris; Samantha J Harris; Susan G Sherman; Brendan Saloner
Journal:  Harm Reduct J       Date:  2022-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.